Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5200
-0.0050 (-0.95%)
Oct 27, 2026, 4:10 PM AEDT
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 179.87 million as of October 27, 2026. It is the 23,425th most valuable company in the world and the 485th biggest in Australia. Its market cap has decreased by 32.30% in one year.
Market Cap
179.87M
Enterprise Value
162.59M
Revenue
86.47M
Global Rank
Country Rank
#485 Australia
PE Ratio
48.42
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 179.87M, a decrease of -55.60%. That is a compound annual growth rate of -12.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 179.87M | -29.55% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 601.03M |
| Imricor Medical Systems | 466.25M |
| EMVision Medical Devices | 143.62M |
| EBR Systems | 105.68M |
| SomnoMed | 65.93M |
| Saluda Medical | 63.01M |
| Lumos Diagnostics Holdings | 62.19M |
| Epiminder | 57.42M |